nephrotic syndrome

Post on 16-Jul-2015

152 Views

Category:

Healthcare

3 Downloads

Preview:

Click to see full reader

TRANSCRIPT

NEPHROTIC SYNDROME

Soumya Ranjan ParidaBasic B.Sc. Nursing 4th year

Sum Nursing College

Nephrotic syndrome

Nephrotic syndrome is 15 times more common in childre than adults.

Incidence – 2-3 / 1lac children /yr

It is characterized by –

- Heavy proteinuria ( > 3.5gm/day or 40mg/m²/hr ),

- Hypoalbuminemia (< 2.5gm/dl ),

- Edema ,

- Hyperlipidemia.

Hematuria , hypertension and impaired renal function are occasionally associated.

Nephrotic SyndromeEtiology –• 90% Idiopathic nephrotic syndrome - Minimal change disease ( 85%), - Mesangial proliferation (5%) , - Focal segmental glorulosclerosis (10%)• 10% Secondary nephrotic syndrome - Membranuous nephropathy - Membranoproliferative GN

Pathophysiology –• T cell dysfunction• Altration of cytokines• Loss of negative charged glycoproteins

Pathophysiology

Heavy proteinuria

Hypoalbuminemia

Reduced plasma oncotic pressure

Extravasation of intravascular fluid

hypovolemia

Aldosterone Antidiuretic hormone

Distal Na & water reabsorption

Edema

Hyperlipidemia –

• Increased hepatic protein synthesis

• Decreased lipoprotein lipase activity

• LDL and VLDL are increased

• HDL may increase, normal or decrease

• Cholesterol and triglyceride are increased

Pathophysiology

Idiopathic Nephrotic SyndromePathology – • Minimal change disease ( 85% ) Minimal increase in mesangium and matrix IFMC – normal EMC – Effacement of epithelial cell foot processes Steriod sensitive – 90%• Mesangial proliferative ( 5% ) LMC - Diffuse increase in mesangium and matrix. IFMC – Mesangial IgM and IgA staining. EMC - Mesangium cell and matrix increased. Effacement of epithelial cell foot processes Steriod sensitive – 50%• Focal segmental glomerulosclerosis ( 10% ) LMC – mesangial proliferation and segmental scarring IFMC – IgM and C3 staing in the area of scarring

Clinical features –

• Sex – M:F 2 : 1

• Age – 2 – 6 yrs

Common –

• Periorbital edema

• Generalized edema

• Oliguria

• Irritability

• Abdominal pain

• Diarrhoea

Uncommon –

• Hypertension

• Gross hematuria

Idiopathic Nephrotic Syndrome

Diagnosis –

Urine examination –

• Proteinuria

• Hematuria

• 24 hour urinary protein

• Spot urine - protein mg% / creatinine mg %

Blood investigations –

• Sreum creatinine

• Total protein

• Serum albumin

• Serum cholesterol and triglyceride level

• C3-C4 levels – N

• IgG- low, IgM - increased

Idiopathic Nephrotic Syndrome

• Glomerular Proteinuria – Selective – LMW & albumin Nonselective – HMW IgG Selectivity = IgG / Transferrin ratio 1gm – 30 gm / day Hematuria , hypertension ,renal insufficiency• Tubular proteinuria – <1gm / day Low molecular proteinuria Little or no albumin • Transient proteinuria• Orthostatic proteinuria.R/o infections – Urine r/m , Urine c/s, Hb ,CBC, ESR , MT test Chest x- ray , USG abdomen.

Idiopathic Nephrotic Syndrome

Treatment

1st episode mild to moderate edema – • Out patient management• Sodium intake restricted initially

• Oral diuretics judiciously.

Severe edema –

• Hospitalized• Fluid restrction• IV diuretics

• 25% human albumin – 0.5gm/kg/12hour

Renal biopsy – • Hematuria, hypertension• Renal insufficiency• Hypocomplementemia

• Age beyond 1-8 yrs

• RBC casts

Prednisone - 60 mg/m²/day divided into 2-3 doses for at least 4wksAfter 4-6 wks - 40 mg/m²/day EOD single morning dose after mealsAfter 3 months – gradually tapered and stopped• Steroid responsive – Urine protein negative, trace or 1+ for 3 consecutive days• Steroid resistant – Urinary protein 2+ or more after 8 wks of therapy.• Steroid dependent – Relapse while on EOD therapy or within 28 days of stopping of steroids.• Relapse – Reappearance of proteinuria 3+ or 4+ and edema.• Infrequent relapse – 3 or less in a year.• Frequent relapse – 4 or more in a year

Treatment

Frequent relapses or steroid dependent – • Prednisolone alternate day – - 0.3 – 0.7 mg/kg: - Duration – 9-12 months• Levamisole – - 2-2.5mg/kg and prednisolone 1.5 mg/kg on alternate days. - Duration: 1 – 2yrs. - Prednisolone dose tapered and discontinued• Cyclophosphamide – - 2 mg/kg daily and prednisolone 1.5 mg/kg alternate days. - Duration : 12 wks• Cyclosporine – - 5 mg/kg daily and prednisolone 1-1.5 mg/kg alternate days. - Duration : 1-3 yrs. - Prednisolone dose tapered

Treatment

Complications

• Edema

• Infection –

- Urinary loss of Ig, properdin factor B

- Defective cell mediated immunity

- Malnutrition , edema, ascitis

- Spontaneous bacerial peritonitis ( Strept. Peumoniae, E.coli )

- Vaccination – pneumococcal, varicella, Infuenza.

• Thrombotic complications –

- Increased prothrombotic factors ( Fibrinogen, thrombocytosis,

hemoconcentration, relative immobilization.

- Decreased fibrinolytic factors ( urinary loss of AT3, protein C, S.

• Acute renal failure

• Steroid toxicity

Secondary Nephrotic Syndrome

• Glomerular diseases –

Membranous GN, MPGN, Lupus & HSP nephritis.

• Infection –

Malaria, Schistosomiasis, HBV, HCV, Filariasis, Leprosy, HIV.

• Malignancy –

Lung and GIT carcinoma, Hodgkins lymphoma

• Druga –

- Membranous GN – Penicillamine, captropil ,gold, NSAIDS,

mercury .

- Minimal change disease – Probencid, ethosuximide,

methimazole, lithium.

- MPGN – Procainamide, chlorpropamide, phenytoin,

trimethadion, paramethadione

• < 3 months

• Finnish type, AR

• Mutation in NPHS1 gene, ch 19, Nephrin

• Pathology –

Dilatation of proximal tubules, mesangial hypercellularity,

glomerular sclerosis

• Clinical features –

Massive proteinuria, large placenta, marked edema,

prematurity, RDS, seperation of cranial sutures

• Treatment -

ACE inhibitors, indomethacin, unilateral nephrectomy

• Denys-Drash syndrome –

Diffuse mesangial sclerosis, Male pseudohermaphroditism,,

Wimls tumor. Mutation in WT1 chromosome

Congenital Nephrotic Syndrome

THANKS

top related